Found: 2
Select item for more details and to access through your institution.
A Phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points.
- Published in:
- British Journal of Cancer, 2005, v. 93, n. 8, p. 876, doi. 10.1038/sj.bjc.6602797
- By:
- Publication type:
- Article
Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer.
- Published in:
- 2004
- By:
- Publication type:
- journal article